Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2022 Dec 13;21:218. doi: 10.1186/s12943-022-01691-w

Correction: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy

Qiang Cai 1,2, Shouhua Wang 1, Longyang Jin 1, Mingzhe Weng 1, Di Zhou 1, Jiandong Wang 1, Zhaohui Tang 1, Zhiwei Quan 1,
PMCID: PMC9745987  PMID: 36514098

Correction: Mol Cancer 18, 82 (2019)

https://doi.org/10.1186/s12943-019-1016-0

In the originally published version of this article [1], after receiving the comment, we have carefully re-checked the raw data and confirmed the error in Fig. 8C. We inadvertently used an image for p62 in ‘GBC-SD/Dox Lv-shRNA+Dox’ from the original images for ATG5 in ‘GBC-SD/Dox Lv-control+Dox’ as we assembled Fig. 8C. We confirm that the mistake would not affect the results or conclusions of the paper. The image of p62 in ‘GBC-SD/Dox Lv-shRNA+Dox’ has now been replaced with the correct one.

Fig. 8.

Fig. 8

Knockdown of GBCDRlnc1 inhibits autophagy and improves the sensitivity of gallbladder cancer cells to Dox in vivo. a The nude micecarrying tumors from NOZ/Dox under different transfection with Dox were shown. Tumor growth curves were calculated per week. b The nude mice carrying tumors from GBC-SD/Dox under different transfection with Dox were shown. Tumor growth curves were calculated per week. c The PGK1, LC3, p62, A TG5 and ATG12 expression and positive cell numbers was determined by immunohistochemical staining. Scale bar = 50 μm (NOZ/Dox) or 100 μm (GBC-SD/Dox). The mean ± SD of triplicate experiments were plotted, *P < 0.05, **P < 0.01, ***P < 0.001

Reference

  • 1.Cai Q, Wang S, Jin L, et al. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol Cancer. 2019;18:82. doi: 10.1186/s12943-019-1016-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES